Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - Am Heart Assoc
Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 …

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - Am Heart Assoc
OBJECTIVE: To determine the association between in-hospital use of ACEI/ARB and all-
cause mortality in patients with hypertension and hospitalized due to COVID-19. METHODS …

[PDF][PDF] Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - scholar.archive.org
OBJECTIVE: To determine the association between in-hospital use of ACEI/ARB and all-
cause mortality in patients with hypertension and hospitalized due to COVID-19. METHODS …

Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension …

P Zhang, LH Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - eprints.gla.ac.uk
Rationale: Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II
receptor blockers (ARBs) is a major concern for clinicians treating coronavirus disease 2019 …

Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu… - 2020 - cabidigitallibrary.org
Objective: To determine the association between in-hospital use of ACEI/ARB and all-cause
mortality in patients with hypertension and hospitalized due to COVID-19. Methods and …

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu… - Circulation …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Rationale:</jats: title>< jats: p> Use of ACEIs (angiotensin-
converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major …

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin… - Circulation …, 2020 - pubmed.ncbi.nlm.nih.gov
Rationale Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 …

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - ingentaconnect.com
Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin
II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 …

[PDF][PDF] Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With …

P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie… - Circulation …, 2020 - scienceopen.com
OBJECTIVE: To determine the association between in-hospital use of ACEI/ARB and all-
cause mortality in patients with hypertension and hospitalized due to COVID-19. METHODS …